In a prospective randomized study in familial hypertrophic cardiomyopathy, metoprolol maintains exercise-performance, with lower myocardial oxygen-cost, and prevents deterioration in exercise-ability
Event: ESC Congress 2019
Topic: Hypertrophic Cardiomyopathy
Session: Clinical, imaging and genetic advances in hypertrophic cardiomyopathy
